Talis Biomedical Announces Appointment of Brian Blaser as President, Chief Executive Officer and Director
15 nov. 2021 16h02 HE
|
Talis Biomedical Corporation
Veteran executive previously led Abbott's global diagnostics organization Kim Popovits, interim chief executive officer, to resume role as Director on the Board of Talis MENLO PARK, Calif., Nov. ...
Talis Biomedical Granted FDA Emergency Use Authorization (EUA) for COVID-19 Molecular Point-of-Care Test to Detect SARS-CoV-2
08 nov. 2021 08h00 HE
|
Talis Biomedical Corporation
Authorized for use in a variety of healthcare and congregate settings, Talis One™ enables lab-quality results without the wait to detect or rule out COVID-19 in less than 30 minutes Talis One’s...
Talis Biomedical to Announce Third Quarter 2021 Financial Results on November 15, 2021
26 oct. 2021 08h00 HE
|
Talis Biomedical Corporation
MENLO PARK, Calif., Oct. 26, 2021 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation ("TLIS"), a company dedicated to developing innovative molecular diagnostic tests for infectious diseases at the...
Talis Biomedical Announces CEO Transition
30 août 2021 16h30 HE
|
Talis Biomedical Corporation
MENLO PARK, Calif., Aug. 30, 2021 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation (Nasdaq: TLIS), a company dedicated to developing innovative molecular diagnostic tests for infectious diseases at...
Talis Biomedical Announces Second Quarter 2021 Financial Results and Business Progress
10 août 2021 16h05 HE
|
Talis Biomedical Corporation
MENLO PARK, Calif., Aug. 10, 2021 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation (Nasdaq: TLIS), a company dedicated to developing innovative molecular diagnostic tests for infectious diseases at...
Talis Biomedical to Announce Second Quarter 2021 Financial Results on August 10, 2021
27 juil. 2021 08h00 HE
|
Talis Biomedical Corporation
MENLO PARK, Calif., July 27, 2021 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation ("TLIS"), a company dedicated to developing innovative molecular diagnostic tests for infectious diseases at the...
Talis Biomedical Announces First Quarter 2021 Financial Results and Business Progress
11 mai 2021 16h05 HE
|
Talis Biomedical Corporation
MENLO PARK, Calif., May 11, 2021 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation (Nasdaq: TLIS), a company dedicated to developing innovative molecular diagnostic tests for infectious diseases at...
Talis Biomedical to Announce First Quarter 2021 Financial Results on May 11, 2021
04 mai 2021 08h00 HE
|
Talis Biomedical Corporation
MENLO PARK, Calif., May 04, 2021 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation ("TLIS"), a company dedicated to developing innovative molecular diagnostic tests for infectious diseases at the...
Talis Biomedical to Participate in Upcoming BofA Securities 2021 Virtual Healthcare Conference
28 avr. 2021 08h00 HE
|
Talis Biomedical Corporation
MENLO PARK, Calif., April 28, 2021 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation (“TLIS”), a company dedicated to developing innovative molecular diagnostic tests for infectious diseases at the...
Talis Appoints Jeryl Hilleman to Board of Directors
18 mars 2021 08h00 HE
|
Talis Biomedical Corporation
MENLO PARK, Calif., March 18, 2021 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation (Nasdaq: TLIS), a company dedicated to developing innovative molecular diagnostic tests for infectious diseases at...